A study to correlate the serum levels of interleukin 6 with the disease activity indices (CDAi and DAS28 ESR) in seropositive rheumatoid arthritis patients
Rana, A.; Gogna, A.; Kabi, B.C.
Journal of the Association of Physicians of India 68(1): 69
2020
ISSN/ISBN: 0004-5772 PMID: 31979688 Document Number: 18046
Document emailed within 1 workday
Related Documents
Ichikawa, Y.; Yamada, C.; Horiki, T.; Hoshina, Y.; Uchiyama, M. 1998: Serum matrix metalloproteinase-3 and fibrin degradation product levels correlate with clinical disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 533-540Al-Awadhi, A.M.; Olusi, S.O.; al-Zaid, N.S.; Prabha, K.; al-Jarallah, K.H.; Ahmed, A.H.; al-Salem, I.; Sedeqi, H.; Atteyah, Y. 1998: Urine levels of type 1 collagen cross-linked N-telopeptides and deoxypyridinoline correlate with disease activity in rheumatoid arthritis Clinical and Experimental Rheumatology 16(5): 569-572
Salaffi, F.; Migliore, A.; Scarpellini, M.; Corsaro, S.M.; Laganà, B.; Mozzani, F.; Varcasia, G.; Pusceddu, M.; Pomponio, G.; Romeo, N.; Maier, A.; Foti, R.; Scarpa, R.; Gasparini, S.; Bombardieri, S. 2010: Psychometric properties of an index of three patient reported outcome (PRO) measures, termed the CLinical ARthritis Activity (PRO-CLARA) in patients with rheumatoid arthritis. The NEW INDICES study Clinical and experimental rheumatology 28(2): 186-200
Shen, H.; Xia, L.; Lu, J. 2013: Interleukin-4 in rheumatoid arthritis patients with interstitial lung disease: a pilot study Indian Journal of Medical Research 138(6): 919-921
Kuuliala, A.; Leirisalo-Repo, M.; Möttönen, T.; Hannonen, P.; Nissilä, M.; Kautiainen, H.; Korpela, M.; Julkunen, H.; Hakola, M.; Repo, H. 2005: Serum soluble interleukin-2 receptor predicts early remission in patients with recent-onset rheumatoid arthritis treated with a single disease-modifying antirheumatic drug Clinical and Experimental Rheumatology 23(2): 243-246
Louthrenoo, W.; Kongtawelert, P.; Sivasomboon, C.; Sukitawut, W. 2001: Correlation between serum hyaluronan and disease activity and severity in Thai patients with rheumatoid arthritis Journal of the Medical Association of Thailand 84(5): 622-627
Boiardi, L.; Macchioni, P.; Salvarani, C.; Rossi, F.; Casadei-Maldini, M.; Mancini, R.; Beltrandi, E.; Portioli, I. 1994: Serum soluble interleukin-2 receptor levels in rheumatoid arthritis: correlation with clinical and immunological parameters and with the response to auranofin treatment Clinical and Experimental Rheumatology 12(4): 357-362
Yildirim, K.; Karatay, S.; Melikoglu, M.Alkan.; Gureser, G.; Ugur, M.; Senel, K. 2005: Associations between acute phase reactant levels and disease activity score (DAS28) in patients with rheumatoid arthritis Annals of Clinical and Laboratory Science 34(4): 423-426
Birrell, F.N.; Hassell, A.B.; Jones, P.W.; Dawes, P.T. 1998: Why not use OSRA? A comparison of Overall Status in Rheumatoid Arthritis (RA) with ACR core set and other indices of disease activity in RA Journal of Rheumatology 25(9): 1709-1715
Haider, S.; Grabovac, I.; Berner, C.; Lamprecht, T.; Fenzl, K-Heinrich.; Erlacher, L.; Quittan, M.; Dorner, T.E. 2019: Frailty in seropositive rheumatoid arthritis patients of working age: a cross-sectional study Clinical and Experimental Rheumatology 37(4): 585-592
Pietrewicz, E.; Urban, M.ła.; Górska, A. 2004: Cytokine levels in serum of patients with juvenile idiopathic arthritis depending on subtype and disease activity Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 17(99): 232-234
Stankovic, A.; Slavic, V.; Stamenkovic, B.; Kamenov, B.; Bojanovic, M.; Mitrovic, D.R. 2009: Serum and synovial fluid concentrations of CCL2 (MCP-1) chemokine in patients suffering rheumatoid arthritis and osteoarthritis reflect disease activity Bratislavske Lekarske Listy 110(10): 641-646
Mihaela Spîrchez; Sama, G.şca; Ianc, M.; Bolba, C.; Miu, N. 2012: Relation of Interleukin-6, TNF-Alpha and Interleukin-1α with Disease Activity and Severity in Juvenile Idiopathic Arthritis Patients Clinical Laboratory 58(3-4): 253-260
Winfield, J.B.; Shaw, M.; Taylor, R.P.; Eisenberg, R.A. 1981: Nature of double-stranded DNA binding activity in seropositive rheumatoid arthritis: formation of low avidity DNA/rheumatoid factor/IgG/low density lipoprotein complexes Journal of Immunology 126(4): 1596-1602
Marhoffer, W.; Schatz, H.; Stracke, H.; Ullmann, J.; Schmidt, K.; Federlin, K. 1991: Serum osteocalcin levels in rheumatoid arthritis: a marker for accelerated bone turnover in late onset rheumatoid arthritis Journal of Rheumatology 18(8): 1158-1162
Cimino, G.; Annino, L.; Giona, F.; Sgadari, C.; Di Gregorio, A.O.; Cava, M.C.; Cimino, G.; Mandelli, F. 1991: Serum interleukin-1 beta levels correlate with neoplastic bulk in hairy cell leukemia Leukemia 5(7): 602-605
Sánchez, T.; Contreras-Yáñez, Iú.; Elías-López, D.; Aguilar Salinas, C.A.; Pascual-Ramos, V. 2014: Prevalence of lipid phenotypes, serum lipid behaviour over follow-up and predictors of serum lipid levels in a cohort of Mexican Mestizo early rheumatoid arthritis patients treated with conventional disease-modifying anti-rheumatic drugs Clinical and Experimental Rheumatology 32(4): 509-515
Bonciani, D.; Antiga, E.; Bonciolini, V.; Verdelli, A.; Del Bianco, E.; Volpi, W.; Caproni, M. 2016: Homocysteine serum levels are increased and correlate with disease severity in patients with lupus erythematosus Clinical and Experimental Rheumatology 34(1): 76-81
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Angelis-Stoforidis, P.; Vajda, F.J.; Christophidis, N. 1999: Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis Clinical and Experimental Rheumatology 17(3): 313-320